This inventor holds 1 USPTO granted patent. Top assignees: Oregon Health & Science University, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2019
Title: Mark Cameron: Innovator in HIV Research
Introduction
Mark Cameron is a notable inventor based in Shaker Heights, Ohio. He has made significant contributions to the field of HIV research, particularly in developing methods to improve vaccine efficacy. His innovative approach focuses on utilizing Ras pathways as markers of protection against HIV.
Latest Patents
Mark Cameron holds a patent titled "Ras pathways as markers of protection against HIV and methods to improve vaccine efficacy." This patent discloses compositions that include a therapeutically effective amount of an HIV immunogen combined with an agent that stimulates the Ras pathway, excluding aluminum salts. The patent also outlines methods for inducing an immune response to HIV and for inhibiting or treating HIV infection in a subject. Additionally, it provides methods for determining the potential of an immunogenic composition to induce a protective response against HIV.
Career Highlights
Throughout his career, Mark Cameron has worked with prominent organizations, including the United States Department of Health and Human Services and Oregon Health & Science University. His work has been instrumental in advancing the understanding of HIV and developing potential therapeutic strategies.
Collaborations
Mark has collaborated with esteemed colleagues such as Shari Gordon and Genoveffa Franchini. Their combined expertise has contributed to the success of his research endeavors.
Conclusion
Mark Cameron's innovative work in HIV research highlights the importance of utilizing novel approaches to enhance vaccine efficacy. His contributions continue to pave the way for advancements in the fight against HIV.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile